PEAK6 Investments’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $14K | Buy |
+297
| New | +$14K | ﹤0.01% | 789 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1195 |
|
|
2024
Q1 | – | Sell |
-175
| Closed | -$11K | – | 1242 |
|
|
2023
Q4 | $11K | Sell |
175
-23,353
| -99% | -$1.46M | ﹤0.01% | 954 |
|
|
2023
Q3 | $1.07M | Buy |
23,528
+13,768
| +141% | +$625K | ﹤0.01% | 329 |
|
|
2023
Q2 | $548K | Sell |
9,760
-40,256
| -80% | -$2.26M | ﹤0.01% | 359 |
|
|
2023
Q1 | $2.26M | Sell |
50,016
-221,829
| -82% | -$10M | 0.01% | 177 |
|
|
2022
Q4 | $11.1M | Buy |
+271,845
| New | +$11.1M | 0.06% | 31 |
|
|
2022
Q3 | – | Sell |
-23,446
| Closed | -$1.38M | – | 1774 |
|
|
2022
Q2 | $1.38M | Sell |
23,446
-148,386
| -86% | -$8.73M | ﹤0.01% | 604 |
|
|
2022
Q1 | $10.8M | Buy |
171,832
+60,114
| +54% | +$3.77M | 0.02% | 64 |
|
|
2021
Q4 | $8.47M | Buy |
111,718
+65,193
| +140% | +$4.94M | 0.02% | 90 |
|
|
2021
Q3 | $5.21M | Buy |
+46,525
| New | +$5.21M | 0.01% | 200 |
|
|
2021
Q2 | – | Sell |
-39,944
| Closed | -$4.87M | – | 1950 |
|
|
2021
Q1 | $4.87M | Buy |
+39,944
| New | +$4.87M | 0.01% | 209 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1536 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1191 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1208 |
|